Forecasting LLM-Enabled Biorisk and the Efficacy of Safeguards
Related Experiment Videos
Bridget Williams1, Luca Righetti2, Josh Rosenberg1
1Forecasting Research Institute, Claymont, Delaware, United States.
Abstract:
Capabilities of large language models (LLMs) on several biological benchmarks have prompted not only excitement about their usefulness for research but also concern about biosecurity risks. We recruited 46 subject-matter experts in biology and biosecurity, and 22 generalist forecasters to estimate the risks of growing LLM capabilities. Most respondents expected some hypothetical LLM capabilities to increase their estimates of risk and dramatically underestimated the rate of LLM progress in those capabilities. When these capabilities arose, the median forecast did update as anticipated. The median expert initially predicted a 0.3% annual risk of a human-caused epidemic that causes 100,000 deaths. This estimate then rose to 1.5% conditional on several hypothetical LLM capabilities, including matching the performance of a top-performing team of virologists on a virology troubleshooting test, which the median expert did not expect to occur until 2030. Given this finding, we conducted a baselining study and found that LLMs already crossed this performance threshold in April 2025. A follow-up survey conducted after these results were available found that forecasters significantly updated their median unconditional risk estimates upward, with the new median expert forecast of annual risk rising to 1.5% (as anticipated by the earlier conditional forecasts). More encouragingly, most experts thought that the adoption of LLM safeguards and mandatory nucleic acid screening would negate the risk associated with some hypothetical LLM capabilities.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Steps in Outbreak Investigation
Hazard Rate
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...